Renal mucormycosis in post-COVID patients in Australia
- PMID: 36816606
- PMCID: PMC9925454
- DOI: 10.1016/j.eucr.2023.102353
Renal mucormycosis in post-COVID patients in Australia
Abstract
Renal mucormycosis is a rare entity that has been described with significant associated morbidity and mortality. It is an opportunistic infection affecting immunocompromised patients. With the pandemic of COVID-19, we report the first case of renal mucormycosis in Australia secondary to COVID-19 and its management.
Crown Copyright © 2023 Published by Elsevier Inc.
Conflict of interest statement
The authors declare that they have no conflicts of interest. No funding was received.
Figures



References
-
- Roden M.M., Zaoutis T.E., Buchanan W.L., et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41(5):634–653. - PubMed
Publication types
LinkOut - more resources
Full Text Sources